Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G S Kellaway

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Pharmacoeconomics|August 6, 1992
Economic constraints and prescribing patterns in New ZealandG S Kellaway
European Journal of Clinical Pharmacology|January 1, 1993
A comparison of the efficacy of cilazapril versus cilazapril plus hydrochlorothiazide in patients with mild to moderate essential hypertension. Inhibace General Practice Study GroupG S Kellaway
Methods and Findings in Experimental and Clinical Pharmacology|August 1, 1980
Facing up to compliance-failure with prescribed drug therapyG S Kellaway
Drugs|January 1, 1976
Adverse drug reactions during treatment of hypertensionG S Kellaway
The New Zealand Medical Journal|March 14, 1979
The effect of counselling on compliance-failure in patient drug therapyG S Kellaway, E McCrae
The New Zealand Medical Journal|September 14, 1977
A pilot trial of labetalol (AH 5158A): a combined alpha and beta blocker in treatment of hypertensionR Dent, G S Kellaway
The New Zealand Medical Journal|June 11, 1975
Non-compliance and errors of drug administration in patients discharged from acute medical wardsG S Kellaway, E McCrae
The New Zealand Medical Journal|December 26, 1973
Intensive monitoring for adverse drug effects in patients discharged from acute medical wardsG S Kellaway, E McCrae
The New Zealand Medical Journal|March 23, 1983
Compliance failure and counselling in paediatric drug therapyG S Kellaway, S A Brown
The New Zealand Medical Journal|June 8, 1988
Catapres-TTS: a two year posttrial followupG S Kellaway, W F Lubbe
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Pharmacoeconomics|August 6, 1992
Economic constraints and prescribing patterns in New ZealandG S Kellaway
European Journal of Clinical Pharmacology|January 1, 1993
A comparison of the efficacy of cilazapril versus cilazapril plus hydrochlorothiazide in patients with mild to moderate essential hypertension. Inhibace General Practice Study GroupG S Kellaway
Methods and Findings in Experimental and Clinical Pharmacology|August 1, 1980
Facing up to compliance-failure with prescribed drug therapyG S Kellaway
Drugs|January 1, 1976
Adverse drug reactions during treatment of hypertensionG S Kellaway
The New Zealand Medical Journal|March 14, 1979
The effect of counselling on compliance-failure in patient drug therapyG S Kellaway, E McCrae
The New Zealand Medical Journal|September 14, 1977
A pilot trial of labetalol (AH 5158A): a combined alpha and beta blocker in treatment of hypertensionR Dent, G S Kellaway
The New Zealand Medical Journal|June 11, 1975
Non-compliance and errors of drug administration in patients discharged from acute medical wardsG S Kellaway, E McCrae
The New Zealand Medical Journal|December 26, 1973
Intensive monitoring for adverse drug effects in patients discharged from acute medical wardsG S Kellaway, E McCrae
The New Zealand Medical Journal|March 23, 1983
Compliance failure and counselling in paediatric drug therapyG S Kellaway, S A Brown
The New Zealand Medical Journal|June 8, 1988
Catapres-TTS: a two year posttrial followupG S Kellaway, W F Lubbe
Pageof 2